Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
It features thorough molecular simulations of the receptor within its native membrane environment, complemented by ensemble virtual screening that considers its conformational mobility. For dimeric or oligomeric receptors, the full functional complex is constructed, and tentative binding sites are determined on and between the subunits to cover the entire spectrum of potential mechanisms of action.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P49238
UPID:
CX3C1_HUMAN
Alternative names:
Beta chemokine receptor-like 1; Fractalkine receptor; G-protein coupled receptor 13; V28
Alternative UPACC:
P49238; A0N0N6; B2R5Z4; J3KP17
Background:
CX3C chemokine receptor 1, known as CX3CR1, plays a pivotal role in immune response, inflammation, and cell adhesion. It acts as a receptor for the chemokine fractalkine, mediating leukocyte migration and exerting functions in tissue compartments. Its involvement in the recruitment of natural killer cells, regulation of inflammation in atherogenesis, and role in airway inflammation highlight its significance in immune modulation. Additionally, CX3CR1 is crucial in brain development, synaptic pruning, and gut microbiota regulation.
Therapeutic significance:
CX3CR1's association with age-related macular degeneration underscores its therapeutic potential. Understanding the role of CX3C chemokine receptor 1 could open doors to potential therapeutic strategies, particularly in treating irreversible vision loss and managing immune-related disorders.